The US Food and Drug Administration on Monday announced the approval of a drug called ubrogepant for the acute treatment of migraine, which could be a new option for people who can't take or don't respond to migraine medications currently on the market.
from CNN.com - RSS Channel - App International Edition https://ift.tt/3728sWh
Subscribe to:
Post Comments (Atom)
Grudge match or homecoming - what next for Pimblett?
Paddy Pimblett is not short of options for his return to fighting despite his loss to Justin Gaethje at UFC 324. from BBC News https://ift...
-
President Donald Trump's phone calls with his lawyer Rudy Giuliani are sparking concerns about whether hostile foreign countries are lis...
-
North Korean leader Kim Jong Un had nothing but praise for "the compatriots in the south" at the start of 2019, speaking of "...
-
A Chinese water park has shut down its "tsunami pool" after a machine malfunction created a massive artificial wave that injured d...
No comments:
Post a Comment